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ABSTRACT
Enterovirus 71 (EV71) infections can lead to devastating clinical outcomes in children, with an increasing
number of severe cases worldwide. The genetic and antigenic variability of EV71 strains isolated in
Taiwan in 1998–2005 was evaluated using partial nucleotide sequence analysis of the VP1 gene and the
neutralisation assay. Phylogenetic analyses revealed that most EV71 isolates from the 1998 epidemic
belonged to sub-genogroup C2, with a minority belonging to sub-genogroup B4. Between 1999 and 2003,
isolates belonging to sub-genogroup B4 predominated, followed by a change to sub-genogroup C4 in
2004 and 2005. Antibodies raised in rabbits or collected from infected patients were able to neutralise
EV71 virus stocks at high dilutions, regardless of the sub-genogroup of the virus being challenged. The
presence of phylogenetically distinct yet antigenically similar populations of EV71 in Taiwan is of
concern in the context of herd immunity and vaccine development.
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INTRODUCTION
Enterovirus 71 (EV71) is a non-enveloped, posit-
ive-strand RNA virus that has been placed in the
genus Enterovirus of the family Picornaviridae
[1,2]. EV71 infection manifests most frequently as
a mild childhood exanthema known as hand, foot
and mouth disease (HFMD) [3–8]. A small pro-
portion of acute EV71 infections is associated with
severe complications, including encephalitis,
aseptic meningitis, pulmonary oedema or hae-
morrhage, and acute flaccid paralysis [3–6,8–18].
Since the initial description of EV71, many out-
breaks of infection with this virus have been
reported periodically in Europe, America and the
Asia-Pacific region [3–9,15,16,19–21]. Since 1997,
EV71 outbreaks with fatalities have been reported
in Asia-Pacific countries [9,22]. During 1998, a
large HFMD epidemic, caused mostly by EV71
infection, occurred in Taiwan, resulting in 405
cases of severe neurological sequelae and
34 deaths. Subsequent smaller EV71-associated
epidemics, including those in 2000 and 2001 with
25 and 26 deaths, respectively, have been reported
almost annually. These periodic EV71 outbreaks
have constituted an important public health issue
in Taiwan [6,23].
For the present study, 404 EV71 isolates from
paediatric patients and their contacts in Taiwan
were collected during 1998–2005 for determination
of the partial VP1 gene sequence of the virus.
Representative isolates were then investigated by
sequence alignments and molecular phylogenetic
analyses. The degree of immunological cross-
reactivity among the virus isolates, based on the
neutralising antibodies, was also determined.
MATERIALS AND METHODS
Specimens
Clinical specimens were collected from the Research and
Diagnostic Center, Centers for Disease Control, Taiwan, or
were obtained from several contracted laboratories throughout
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the country during 1998–2005. Samples were from fatal cases
and patients afflicted with HFMD, herpangina, pharyngeal
vesicle, acute encephalitis and acute flaccid paralysis, together
with their contacts. Samples included a wide range of clinical
specimens, e.g., throat swabs, rectal swabs, stools, sera,
medulla and cerebrospinal fluid (Table S1; see Supplementary
material).
Viruses
Detailed information concerning the virus strains used in this
study is given in Table S1. In brief, viruses were cultured and
isolated from clinical samples using rhabdomyosarcoma and
Vero cells grown in Minimum Essential Medium (MEM)
containing fetal bovine serum 10% v ⁄v and penicillin ⁄ strep-
tomycin ⁄ amphotericin B, incubated at 37C in CO2 5% v ⁄v.
Viruses were identified by an indirect immunofluorescent
stain using a monoclonal antibody against EV71 (Chemicon
International, Temecula, CA, USA).
RNA extraction and RT-PCR
Virus RNA was extracted from 140 lL of virus culture
supernatant using a QIAmp Viral RNA kit (Qiagen, Valencia,
CA, USA) according to the manufacturer’s instructions.
RT-PCR was performed in 20-lL reaction mixtures containing
5 mM MgCl2, 1 · reaction buffer, 10 mM each dNTP, 1 U of
RNase inhibitor, 2.5 U of Maloney murine leukaemia virus
reverse transcriptase (Perkin Elmer, Foster City, CA, USA),
10 pmol of EV71-specific primer 159 [19] and 1–2 lL of
extracted RNA. RT-PCR conditions were 42C for 15 min,
followed by 99C for 5 min and 5C for 5 min.
After cDNA synthesis, 80 lL of PCR reaction mix was
added to the same tube to give a final concentration of 2.0 mM
MgCl2, 1 · PCR buffer, 2.5 U of Taq and 10 pmol of EV71-
specific primer 162 [19]. Amplification conditions comprised
35 cycles of 94C for 30 s, 50C for 30 s and 72C for 1 min.
PCR products (485 bp in length) were visualised by agarose
gel electrophoresis.
Sequencing
RT-PCR products were purified with a QIAquick PCR puri-
fication kit (Qiagen) and then subjected to dye terminator cycle
sequencing (Applied Biosystems, Foster City, CA, USA). The
products were then analysed in an automated model 377 DNA
sequencer (Applied Biosysems). Nucleotide positions 16–429
in the VP1 gene were sequenced in both directions to resolve
possible ambiguous nucleotides.
Phylogenetic analysis
Eighty-five EV71 isolates were used for sequence alignment and
phylogenetic analysis following random sampling of a total of
404 EV71 isolates. Alignment and pairwise comparisons of
414 bp of the partial VP1 gene sequence were performed using
CLUSTAL W [24]. Pairwise nucleotide and amino-acid
comparisons were performed using the Distance program of
the MegAlign DNASTAR package (DNASTAR, Madison, WI,
USA). Phylogeny construction and evaluation were performed
using PHYLIP software (http://evolution.genetics.washington.
edu/phylip.html) and the maximum-likelihood program, with
the EV71 prototype BrCr strain as the outgroup and 53 EV71
worldwide reference strains for comparison (Table S2; see
Supplementary material). The evolutionary distances were
calculated using the Felsenstein model. The partial VP1
sequences of EV71 isolates investigated in this study have been
deposited in the GenBank database under the accession
numbers shown in Table S1.
Neutralisation assay
Sera were obtained from individuals with enterovirus-associ-
ated syndromes. Heat-inactivated (56C for 30 min) sera were
serially diluted in four-fold steps in MEM containing fetal
bovine serum 2% v ⁄v (MEM-2), with an initial serum dilution
of 1 : 8. The tissue culture infectious dose (TCID50) of the virus
stocks was determined and then diluted 10-fold, 102-fold and
103-fold with MEM-2. Diluted sera and virus samples were
mixed (50 lL of each), and the mixture was incubated at 37C
for 1 h. The virus–serum mixtures were then inoculated on
70%-confluent rhabdomyosarcoma cells in a 96-well dish and
monitored for the development of the characteristic cytopathic
effect for 4 days. The neutralising titre of a particular serum
and virus was defined as the reciprocal of 50% of the highest
dilution that resulted in no observable cytopathic effect.
Immunisation of rabbits
A stock of EV71 strain 11207 (Table S1) was prepared and
inactivated by UV light before use as an immunogen to elicit
antisera in rabbits. Sera were collected from two New Zealand
White rabbits (c. 1.9 kg each) before immunisation. The two
rabbits were inoculated subcutaneously with 5 mL of inacti-
vated strain 11207 virus stock (108.8 TCID50 ⁄mL; Table S1), and
this was followed by boosting four times at 2-day intervals.
Ten-millilitres of virus stock (without being inactivated) was
used for a final boost at 42 days after the first inoculation; sera
were drawn from the immunised animals c. 1 week after the
final boost.
RESULTS
Nucleotide sequence analyses
Representative EV71 strains (Table S1), including
12, eight, 13, 13, seven, five, 15 and 13 isolates
from each year between 1998 and 2005, respect-
ively, were investigated for their genetic diversity.
The ages of patients and their contacts ranged
from 4 months to 10 years, with 78 (92%) of the
subjects being aged <5 years. There were 58 boys
and 27 girls, giving a male:female ratio of c. 2 : 1.
RT-PCR followed by sequencing was performed
for the genomic region corresponding to part of
capsid protein VP1, shown to contain serotype-
specific information and to be suitable for inves-
tigations of the molecular epidemiology and
genetic diversity of enteroviruses [25–27]. DNA
sequences for nucleotide positions 2454–2867
(corresponding to amino-acid positions 571–708)
Kung et al. Enterovirus 71 in Taiwan 783
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 782–787
were determined and compared with the
sequences from 53 worldwide strains of EV71,
including the BrCr prototype and eight Taiwan-
ese strains described previously (Table S2).
The phylogenetic tree generated by the maxi-
mum-likelihood method comprised two major
genogroups, i.e., genogroups B and C, that were
distinct from the original genotype A (81.1–84.1%
and 82.6–87.1% identity, respectively) which con-
tained the prototype BrCr strain (Fig. S1; see
Supplementary material). The present study also
identified sub-lineages, namely B4, C2 and C4
(Fig. S1 and Table S1), with the identities of
isolates within each sub-genogroup being within
the range 94.9–100% (Table 1).
Only a small proportion of the virus isolates
circulating in the 1998 EV71 Taiwan epidemic was
identified as sub-genotype B4, as exemplified by
isolates 1263 and N5101TW-98 (a reference strain)
(Fig. S1, Tables S1 and S2). In addition, a single
reference strain (TW-1743-98) from 1998 was
assigned to the B1 sub-genogroup. Sub-genotype
B4 isolates became predominant during 1999–
2003. These Taiwanese sub-genotype B4 isolates,
with the exception of isolates 99263 and 1263,
were clustered together within a clade, whereas
the B4 reference strains from Malaysia (0343-
MAA97), Sarawak (S19791-SAR-03), Singapore
(5511-SIN-00) and Japan (786-Yamagata-00 and
962-Yamagata-00), which also circulated during
the same period, formed separate clusters
(Fig. S1).
The most prevalent genogroup C isolates in the
1998 EV71 Taiwan epidemic were identified as
belonging to the C2 sub-genogroup (Fig. S1).
However, this group of Taiwanese isolates failed
to cluster with other C2 isolates, including the
1997 Japan strain (1095 ⁄ JPN ⁄ 97), the 1997 North
America strain (2355-OK-97), the 1997 Malaysia
strain (2381-MA-97) and the 1999 Australia strain
(27M ⁄AUS ⁄ 2 ⁄ 99) (Table S2). The genogroup C
viruses were not prevalent between 1998 and
2004, after which the majority belonged to the C4
sub-genogroup. Notably, the C4 Taiwanese iso-
lates clustered with two reference strains collected
in mainland China during 2003, i.e., the shzh03
and SHZH03-58 strains (93.0–95.7% and
93.3–96.9% identities, respectively), suggesting a
possible genetic and epidemiological linkage. In
contrast, neither the Taiwanese sub-genotype C4
isolate (1341) from 1998, nor isolates 2001-336 and
2001-522 from 2001, clustered with isolates from
2004 and 2005 (Fig. S1, Tables S1 and S2).
Analyses of amino-acid sequences
The deduced amino-acid sequences encoded by
the sequenced VP1 region of the EV71 isolates
studied were analysed by comparing all possible
sequence pairs (Table 1). The amino-acid
sequences of the majority of EV71 isolates were
highly conserved, with >97.8%, 96.4% and 94.2%
identities within the sub-genogroups B4, C2 and
C4, respectively. Certain specific amino-acid res-
idues in the sequenced region were found to be
uniquely conserved within a certain genogroup;
e.g., Glu-43 and Thr-58 of the VP1 protein
appeared to be specific for genogroup B, while
Lys-43 and Ala-58 were unique for genogroup C,
based on findings for 177 and 227 isolates belong-
ing to genogroups B and C, respectively. Deduced
VP1 amino-acid sequences of the EV71 isolates
responsible for mild, severe and fatal cases
between 1998 and 2005 did not reveal a specific
pattern of amino-acid residues that was associated
with the pathogenesis of EV infection.
Table 1. Pairwise nucleotide and amino-acid sequence comparisons of partial VP1 sequences among enterovirus 71 sub-
genogroupsa
Subgroup
B1 B2 B3 B4 C1 C2 C3 C4
nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa
B1 95.2–98.6 99.3–100 90.5–92.4 97.1–99.3 90.1–92.0 97.6–99.2 85.3–89.4 96.8–99.3 80.4–84.6 97.1–98.6 82.2–85.2 94.9–97.1 82.9–84.3 97.1–98.6 82.9–84.5 96.4–97.6
B2 96.6–98.3 98.3–100 93.0–94.0 97.8–99.2 89.2–90.4 97.8–98.6 81.0–83.6 97.1–98.6 81.4–83.3 94.9–97.1 82.2–83.1 96.4–99.3 83.1–86.5 95.1–97.6
B3 98.3–99.8 99.3–100 92.0–94.9 98.6–99.3 83.1–84.6 97.1–98.6 82.4–84.8 94.9–97.1 82.7–83.1 97.8–98.6 82.7–85.8 97.1–97.6
B4 94.9–99.8 97.8–100 81.9–84.8 96.4–98.6 82.2–85.3 94.9–97.1 84.6–86.3 97.1–98.6 83.9–87.0 95.7–97.6
C1 94.7–100 99.3–100 90.6–92.5 97.1–98.6 89.1–92.0 96.4–98.6 88.7–89.3 95.7–98.8
C2 96.4–98.5 96.4–100 89.1–91.8 96.4–98.6 88.4–91.0 95.7–97.6
C3 99.9–100 99.3–100 89.9–92.0 94.9–97.8
C4 94.9–100 94.2–100
aThe data indicate the range of similarity (%) in the pairwise comparisons.
nt, nucleotide; aa, amino-acid.
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Antigenic analyses
To determine whether a correlation existed
between the genetic and antigenic properties of
these viruses, two sets of experiments were
conducted using sera from either two immunised
rabbits or from infected patients.
First, ten selected EV71 isolates from each
genogroup were characterised by neutralisation
with rabbit antisera raised against EV71 isolate
11207, obtained from a child who suffered from
acute flaccid paralysis and died of a confirmed
EV71 infection during the 1998 Taiwan outbreak.
The titres of neutralising antibodies for each virus
isolate examined were 1:320–1:11 200 for rabbit
serum no. 1, and 1:1408–1:32 768 for rabbit serum
no. 2 (Fig. 1), whereas those of pre-immune rabbit
sera were all <1:4. For a particular virus isolate,
the titre of antiserum raised in rabbit no. 2 was
normally higher than that from rabbit no. 1
(Fig. 1), suggesting distinct levels of immune
response towards a specific virus strain in an
individual rabbit.
Second, cross-neutralisation experiments were
performed to evaluate the capacity of sera from
patients infected with a particular EV71 genotype
(seven and six sera from patients infected by
genogroup B and C viruses, respectively) to neu-
tralise representative isolates of other genotypes
(Table 2). The antisera from the infected patients
effectively neutralised the homologous EV71 iso-
lates, with all titres being >1024. The titres of the
antisera for different genogroups of EV71 were
also fairly high, ranging from 512 to >1024. These
were in marked contrast to those from individuals
infected by viruses other than EV71, including
two echovirus 6 strains, a coxsackievirus B5
strain, a coxsackievirus A16 strain and a herpes
simplex virus 1 strain, for which the titres ranged
from <8 to 128 (Table 2). Taken together, these
results indicate a close antigenic relationship
among the EV71 isolates belonging to genogroups
B and C.
DISCUSSION
A sentinel surveillance system organised by the
Taiwan Health Authority detected several waves
of EV71 outbreaks during the years 1998–2005 in
Taiwan [6,23]. EV71 has thus become an endemic
agent that accounts for mild syndromes such as
HFMD and herpangina and, more importantly,
neurological manifestations and fatal cases in
children. As part of the work of the task force
for the control of recurrent EV71 epidemics, the
aims of the present study were to analyse the
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Fig. 1. Neutralisation antibody titres of rabbit antisera
against enterovirus 71 strains of distinct sub-genogroups
(Table S1, see Supplementary material): A, strain 11207
(sub-genogroup C2); B, strain 1263 (sub-genogroup B4);
C, strain 1341 (sub-genogroup C4); D, strain 0815 (sub-
genogroup C2); E, strain 99214 (sub-genogroup B4);
F, strain 00005 (sub-genogroup B4); G, strain 00260 (sub-
genogroup B4); H, strain 2001-122 (sub-genogroup B4);
I, strain 2002-042 (sub-genogroup B4); J, strain 2004-104
(sub-genogroup C4).
Table 2. Neutralisation antibody titres for selected sera
against the representative genogroups B and C of entero-
virus 71 (EV71) viruses
Sera
Virus
Genogroup Ba Genogroup Cb
Anti-genogroup Bc
B1 >1024 1024
B2 >1024 1024
B3 >1024 >1024
B4 >1024 512
B5 >1024 1024
B6 >1024 512
B7 >1024 >1024
Anti-genogroup Cd
C1 >1024 1024
C2 >1024 1024
C3 >1024 1024
C4 >1024 512
C5 >1024 1024
C6 >1024 1024
Non-EV71 antisera
EV6 no. 1 64 64
EV6 no. 2 128 128
CB5 <8 <8
CA16 <8 <8
HSV-1 <8 <8
aStrain 2002042 (Table S1; see Supplementary material).
bStrain 2004104 (Table S1; see Supplementary material).
cSera from individuals infected by EV71 strains of genotype B (B1–B7).
dSera from individuals infected by EV71 strains of genotype C (C1–C6).
EV6, echovirus 6; CB5, coxsackievirus B5; CA16, coxsackievirus A16; HSV-1, herpes
simplex virus 1.
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phylogeny and the possible relationships among
the genotypic and antigenic properties of the
EV71 isolates collected during this period.
Based on the nomenclature of Brown et al. [19],
the major sub-genogroup causing the 1998
Taiwan epidemic was identified as C2, with a
few co-circulating strains belonging to sub-geno-
groups B1 (not isolated in this study) and B4.
Between 1999 and 2003, the predominant strains
belonged to the B4 sub-genogroup, and this was
followed by a shift to sub-genogroup C4 in 2004
and 2005.
Several studies have described phylogenetic
analyses of EV71 strains, based on the VP1
[7,19,28–30], VP4 [28,31,32] and 5¢-untranslated
region [23,30] genomic regions. As the nucleotide
sequences of the VP4 region and 5¢-untranslated
region are generally more conserved, they have
lower discriminating power and correlate only
partially with serotype [20,33]. In contrast, the
VP1 region is considered to be a variable region
and to play an important role in characterising
antigenicity [25–27]. Moreover, analysis of the
truncated VP1 segment (nucleotides 16–429 of the
VP1 nucleotide sequence) with a single universal
primer pair for RT-PCR and sequencing, as
described above, is a simple and convenient
screening method for the characterisation
of EV71 isolates. The sub-genogrouping data
obtained in the present study correlated well
with data obtained using the full-length VP1
sequence [19,21,22,28,29].
EV71 outbreaks with fatal cases have been
reported in countries in the Asia-Pacific region
since 1997 [19–21]. All three sub-genogroups
detected in the present study have been circula-
ting in the Asia-Pacific region throughout the
study period, suggesting possible importa-
tion ⁄ exportation of EV71 viruses among neigh-
bouring regions. This is substantiated by the
finding that the Taiwanese sub-genogroup C4
viruses isolated since 2004 formed a cluster with
the reference strains collected in mainland China
during 2003 (Fig. S1). However, the Taiwanese
sub-genogroup C4 isolates did not cluster with
sub-genogroup C4 isolates in 1998 (strain 1341)
and 2001 (strains 2001-336 and 2001-522). The
present investigation suggests that the C4 viruses
circulating in Taiwan since 2004 were probably
derived from the Chinese strains, consistent with
the phylogenetic study based on the VP4 segment
reported previously [31]. However, neither the
Taiwanese sub-genogroup C2 isolates from 1998,
nor the Taiwanese sub-genogroup B4 isolates
from 1999 to 2003, clustered with the correspond-
ing sub-genogroup viruses from the Asia-Pacific
countries during the same period (Fig. S1), sug-
gesting that there may be genetically diverse
sources for both sub-genogroups in Taiwan.
While distinct sub-genogroups of EV71 were
identified, antigenic cross-reactivity was demon-
strated among these isolates, which is the first
report of this phenomenon. It is reasonable to
assume that there are common epitopes, either
linear- or conformational-dependent, shared by
the viruses, although further research with a panel
of EV71 monoclonal antibodies is required. This
finding does not support the concept that periodic
change of the predominant sub-genotype in each
epidemic is a consequence of an accumulation of
immunological resistance to viruses of a particular
sub-genotype in the population, which may be of
benefit in the development of vaccination
strategies against this virulent enterovirus.
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